During the past decade, Gujarat Cancer & Research Institute (GCRI) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gujarat Cancer & Research Institute (GCRI)" #1 sponsor was "Pfizer" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "CureTech Ltd" with 1 trials sponsored, "Partha Basu" with 1 trials sponsored and "Tata Memorial Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gujarat Cancer & Research Institute (GCRI)" #1 collaborator was "All India Institute of Medical Sciences, New Delhi" with 2 trials as a collaborator, "Basavatarakam Indo- American Cancer Hospital (BIACH)" with 1 trials as a collaborator, "Cancer Foundation of India" with 1 trials as a collaborator, "Christian Fellowship Community Health Centre" with 1 trials as a collaborator and "Deutsches Krebsforschungszentrum (DKFZ)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Gujarat Cancer & Research Institute (GCRI)" are "Advanced Non-Small Cell Lung Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Cervical Cancer" (1 trials), "Cervical Precancerous Lesions" (1 trials) and "Lymphoma, Large Cell, Diffuse" (1 trials). Many other conditions were trialed in "Gujarat Cancer & Research Institute (GCRI)" in a lesser frequency.

Most popular intervention types in "Gujarat Cancer & Research Institute (GCRI)" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.5% lignocaine 60mM" (1 trials), "BIBW 2992" (1 trials), "CT-011" (1 trials), "Dacomitinib" (1 trials) and "Lorlatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gujarat Cancer & Research Institute (GCRI)" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Gujarat Cancer & Research Institute (GCRI)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Gujarat Cancer & Research Institute (GCRI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gujarat Cancer & Research Institute (GCRI), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".